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The National Aeronautics and Space Administration (NASA) has performed many experiments 
on the International Space Station (ISS) to further understand how conditions in space can affect 
life on Earth. This project analyzed GLDS-258, a gene set from NASA’s GeneLab repository 
which examines the impact of microgravity on human induced pluripotent stem-cell-derived 
cardiomyocytes (hiPSC-CMs). While many datasets have been run through NASA’s RNA-Seq 
Consensus Pipeline (RCP) to study differential gene expression in space, a Homo sapiens dataset 
has yet to be analyzed using the RCP. The aim of this project was to run the first Homo sapiens 
dataset, GLDS-258, through the RCP on the San Jose State University College of Engineering 
High Performance Computing Cluster and investigate any biological significance from the 
results. In this study, a total of 18 hiPSC-CMs samples from ground control, flight, and post-
flight groups are run through the RPC. The resulting differential gene expression data was 
further analyzed for biological significance using the Database for Annotation, Visualization, 
and Integrated Discovery (DAVID) and Gene Set Enrichment Analysis (GSEA). Results showed 
that most genes were differentially expressed in ground control versus flight groups, while post-
flight groups and ground control groups did not have as many differentially expressed genes. 
Gene set analysis showed significant expression of genes in mitochondrial pathways as well as 
genes related to neurodegenerative diseases such as Alzheimer’s, Huntington’s, and Parkinson’s 
disease. These results indicate that exposure to microgravity may play a role in altering 
expression of genes which are related to neurodegenerative pathways in cardiac cells. Our results 
demonstrate that it is possible to process Homo sapiens data through the RPC, and suggest that 
cardiomyocytes exposed to microgravity may exacerbate neurodegenerative disease progression. 
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I. INTRODUCTION 
 
A. The Human Body and Space 
 
Space travel has long been one of humanity’s greatest curiosities and persisting interests. As 
modern-day technologies advance, space exploration continues to become more accessible and 
space missions can increase in number. NASA’s Perseverance Rover’s successful landing on 
Mars on February 18, 2021 is a prime example of what is possible in the field of space 
exploration in years to come [1]. This is a monumental achievement for mankind and will 
undoubtedly pave the way for future missions, including bringing astronauts back to the Moon 
and to Mars [3], [4]. NASA plans to bring astronauts, including the first woman, to the Moon by 
the year 2024 on the Artemis Lunar Exploration Program [4]. The upcoming mission to the 
Moon will demonstrate new space travel technologies and possibilities, while also capturing the 
imagination of the younger generation and people around the world [4]. 
However, space travel can be accompanied by adverse impacts on the human body since 
environments in outer space are very different from the conditions in which life on Earth 
evolved. The main concerns that studies have been focused on include space radiation, isolation 
and confinement, distance from Earth, gravity fields, and hostile or closed environments [2]. 
Among these factors, exposure to radiation and microgravity have been studied extensively in a 
scientific setting. Exposure to space radiation can be a long-term issue for astronauts because it 
can harm cell DNA repair mechanisms and possibly lead to development of cancer or other 
detrimental illnesses [3]. Similarly, astronauts who were exposed to microgravity for extended 
periods of time exhibited changes to several systems in their body, including musculo-skeletal, 
cardiovascular, nervous, and immune systems [4]. While these have been many counter 
measures implemented to alleviate some of the effects of these hazards, more research is 
required to understand how to best protect our astronauts’ health and safety. 
 
B. Cardiomyocytes: Cardiac Cell Muscle 
  
Cardiomyocytes are the muscular cells within the heart that allow the organ to contract and 
relax properly to provide blood throughout the body [5]. The contracting motions are regulated 
by ion channels that manage the entry and exit of Ca2+ into the cardiac cells [5]. 
Cardiomyocytes are difficult to study in culture for two major reasons. First, cardiomyocytes 
are not likely to divide after birth and therefore are also not likely to replicate in culture [5]. 
Second, to isolate the cardiomyocytes, the intercalated disks may become damaged that lead to 
increased intake of Ca2+ [7]. As a result, cell death will occur due to hypercontraction [7]. 
Figure 1 below depicts cardiomyocyte structure.  
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Figure 1: Graphical representation of cardiomyocyte structure [6] 
 
C. Cardiomyocytes and Space Flight 
 
NASA has performed an abundance of studies throughout the years regarding the 
cardiovascular system and human health. There has been substantial evidence to conclude that 
spaceflight will affect human cardiac function. One of the most famous studies, the NASA Twin 
Study, showed that arterial pressure will decrease while total cardiac output increases when an 
astronaut is exposed to a long-term microgravity environment [7]. In this study, identical twins 
Mark Kelly and Scott Kelly were observed after Scott lived in space for a year and Mark 
remained on Earth as a ground control. Other studies have confirmed similar findings, in which 
individuals have lowered arterial pressure and decreased heart rate [8]. While there have been 
several conclusive studies regarding the human cardiovascular system as a whole, studies of 
cardiac function at the cellular level have been limited due to the difficulty of studying 
cardiomyocytes in culture.  
Animal models have historically been a popular choice when studying the relationship 
between microgravity and cardiomyocytes at the cellular level since human trials are 
complicated and costly. In particular, mice and rats have been used for several of these 
experiments. A study published in 1992 found that rat cardiac myosin, a protein that plays an 
important role in muscle contractions, had mRNA expression that was impacted when the rats 
were exposed to microgravity for 14 days [9]. A separate experiment concluded that short 
exposure to microgravity increases the expression of various rat cardiomyocyte mitochondrial 
enzymes [10]. These are two among many other animal model-based experiments performed in 
the last several decades. While these past experiments have provided valuable insight into the 
relationship between microgravity and mammalian cardiomyocytes, animal models cannot 
provide a completely exhaustive and conclusive results for the human body. NASA continues to 
seek more informative results by utilizing new technologies that allow us to perform experiments 
on human cardiomyocytes. 
 
 - 10 - 
D. NASA GeneLab’s RNA-Seq Consensus Pipeline 
 
NASA’s GeneLab project aims to create the GeneLab Data System (GLDS) repository, 
which hosts molecular data from spaceflight mission samples [11]. Additionally, GeneLab hopes 
to process these datasets to provide more knowledge about how life on Earth changes in space 
[12]. The current version of the repository, GLDS 3.0, contains over 200 datasets from around 
the world [12]. As more datasets are uploaded to GLDS, NASA has developed methods to 
visualize and analyze the data on their repository. 
GeneLab’s RNA-Sequence Consensus Pipeline (RCP) is one method NASA has developed 
to process datasets upload to GLDS. The pipeline is designed to analyze short-read RNA-
sequence data, and includes several steps that will ultimately detect any differentially expressed 
genes [12]. A variety of datasets can be run through the pipeline, including Homo sapiens, Mus 
musculus, Drosophila melanogaster, among others [13]. The three major steps of the pipeline are 
data pre-processing: quality control and trimming, data processing: read mapping and sample 
quantification, and finally differential gene expression calculations and gene annotations. GLDS 
contains more than 80 RNA sequencing datasets as of August 2020, and many of these sets have 
yet to be run through the pipeline. The process can take several hours and typically requires the 
user to manually run various scripts throughout the process [13]. A more streamlined, Nextflow 
implementation of the pipeline has been created by former San Jose State University student 
Jonathan Oribello; it requires little to no manual intervention throughout the process [13]. Since 
the Nextflow implementation of the pipeline was originally tailored to run Mus musculus 
datasets, this paper briefly examines how to run a Homo sapiens dataset through the Nextflow 
version of the pipeline. However, analysis will be focused around the output from manually 
running customized scripts from the pipeline since the Nextflow implementation for Homo 
Sapiens is still in development. 
 
E. GeneLab Dataset 258 
 
This paper focuses on the dataset GLDS-258, which contains RNA sequence data from 
human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provided by Joe 
Wu’s group from Stanford University School of Medicine [14]. There are three distinct cell lines 
in this study: four and a half weeks of microgravity exposure, five and a half weeks of 
microgravity exposure with ten days of Earth gravity, and a control with five and a half weeks 
and 10 days of Earth gravity [15]. Each cell line had six samples for a total of 18 samples and 
were all generated from three individuals and differentiated into hiPSC-CMs using the 2D 
monolayer differentiation protocol [15]. Cell lines that were exposed to microgravity were sent 
to the ISS on a SpaceX Falcon 9 rocket during a resupply mission [15]. Figure 2 below depicts 
an overview of the process Wu’s research group used to obtain the data, along with types of 
analysis used after obtaining the data. 
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Figure 2: Graphical representation of the timeline for the entire experiment,  
Reprinted with permission obtained from Joe Wu from the  
Stanford University School of Medicine [15]. 
 
The raw reads gathered from these cell lines were analyzed using a different protocol from 
the RNA-Seq Consensus Pipeline [15]. Upon completion of the experiment, Wu’s research group 
completed nucleic acid sequencing using Illumina HiSeq to create paired end reads with a 100 
base pair length [15]. Their group aligned the raw reads to the hg38 human genome using 
HISAT2 [15]. The researchers then utilized featureCounts along with the Ensembl 85 annotation 
file to quantify the raw reads [15]. Finally, the genes were normalized and determined to be 
differentially expressed using the DESeq2 tool [15]. The results from this method of data 
analysis found that 2,635 genes were differently expressed based on a p-value of 0.05 [15]. 
While these methods work well, they are different from the protocol in NASA’s RCP. The 
analysis in this paper of GLDS-258 will follow NASA’s RCP and use more recent human 
reference genomes and annotations, since the hg38 human genome and Ensembl 85 references 
are from 2013 and 2016, respectively [15], [16]. This dataset will be the first Homo Sapiens 
dataset to be run through the RCP, and hopefully provide the groundwork for future Homo 
Sapiens datasets as well. 
 
II. METHODS 
A. Computational System 
 
Analysis of the GLDS-258 dataset requires a large number of computational resources, and 
therefore cannot be performed on most personal machines. In order to successfully process the 
dataset in a timely manner, the San José State University (SJSU) College of Engineering (CoE) 
High Performance Computing (HPC) system was used to implement the RCP. The HPC cluster 
is a Linux based machine with 36 nodes, each with either 128GB or 256GB of RAM, for a total 
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memory of 6.7TB for the entire cluster [17]. The Slurm Batch scheduler was used to deploy jobs 
onto the HPC. 
 
B. RCP Overview and Steps 
 
Raw reads for GLDS-258 were obtained from NASA GeneLab’s online repository, in the 
form of compressed fastq files. The raw data was prepared on the Illumina HiSeq platform and 
submitted by Dr. Joe Wu’s research group. After downloading the data from NASA GeneLab’s 
website, analysis using the RCP can begin. 
 
 
Figure 3: Overview of the RCP [11] 
 
A high-level overview of the workflow for the RCP is shown in Figure 3. In general, the 
pipeline will take input in the form of compressed fastq files, and output csv files and diagrams 
with analyzed data [11]. Each of the steps below were completed by running an adapted Slurm 
script originally provided by Dr. Amanda Saravia-Butler from NASA GeneLab.  
 
1) Raw Data Quality Control 
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The first step of the pipeline is to perform quality control with FastQC and MultiQC; 
these are two bioinformatics programs that were developed to streamline the process of assessing 
the quality of RNA sequence reads [18], [19]. FastQC and MultiQC versions 0.11.9 and 1.9 were 
used, respectively.   
 
2) Pre-processing Data 
 
The next step of the pipeline is to pre-process the raw sequence data. TrimGalore! Is  
a script that wraps around Cutadapt and FastQC to filter unnecessary or bad quality data 
[20]. Pre-processing is a necessary step to remove low quality reads, remove adapters,  
and remove any reads that have become too short in the trimming process [20]. TrimGalore! and 
Cutadapt version 0.6.6 and 3.2 were used, respectively. 
 
3) Align and Count Reads 
 
After pre-processing the data, the reads must be aligned to a reference genome by 
building a STAR index. The STAR tool requires a reference genome in the form of a fasta file, 
along with a GTF annotation file [21]. Both human genome fasta and GTF annotation files are 
from Ensembl release 102, and STAR version 2.7.7a was used. 
RSEM is a weighted quantitation tool that uses a maximum likelihood estimation to 
match reads to genes [22]. RSEM version 1.3.1 was used for quantification. 
 
4) Differential Gene Expression and Normalization Using R 
 
A R script provided by Dr. Amanda Saravia-Butler was modified then used in order to 
perform differential gene expression using DESeq2. Analysis was completed using R version 
4.0.5. Data visualization was also performed using R with the differential gene expression data 
output from DESeq2. 
The R script followed the following steps. First, DESeqDataSet object is created. We 
filter out all genes with counts of 10 or less across all conditions. Then, 
estimateSizeFactors() is called on the DESeqDataSet object. This function estimates 
the size factors with a median ratio method. A size factor is created for every sample by dividing 
the median ratio of all the counts by the mean of the genes for all samples. Each sample’s raw 
counts are then divided by the size factor created in the last step.  
The next function to be called on the object is estimateDispersions(), which 
gathers dispersion estimates for a negative binomial distribution of data. The calculations will 
assume that the gene set counts will follow a negative binomial distribution, which is why this 
method is used. Each dispersion per gene is found by maximizing the Cox Reid-adjusted profile 
likelihood [23]. Essentially, the dispersion for each gene will describe how much of the 
expressed variance across the samples deviate from the mean of the gene’s expression. 
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Finally, the function nbinomWaldTest() is called on the DESeqDataSet object. This 
function tests for any significance of coefficients in a Negative Binomial distribution, and will 
utilize the dispersion estimates from the estimateSizeFactors() and 
estimateDispersions() functions which were previously called. The Wald test will 
calculate the p-value that a gene’s expression is significant when compared to a null hypothesis. 
The raw count and normalized data are then exported. 
Adjusted p-values are calculated using the Benjamini-Hochberg technique. The false 
discovery rate used for this calculation is the default at 0.1. Finally, all data analysis is performed 
using the output table from DEDeq2. In the R script, multiple Principal Component Analysis 
(PCA) graphs were created, along with a heat map comparing all three groups.    
 
C. Nextflow Implementation of RCP for Human Genome 
 
The Nextflow implementation was initially created and tailored the analyze the GLDS-104 
dataset, which is an experiment using mouse samples [12]. In order to run GLDS-258 using 
Nextflow, certain configuration files and changes need to be made since GLDS-258 uses human 
samples. Since the Nextflow implementation is not the official standard for analyzing NASA 
GeneLab data, the output which was used for analysis is from manually running the RCP for 
GLDS-258, in case there are any unknown discrepancies between the two analysis workflows. 
This section will briefly discuss and show examples of configuration files used for running the 
pipeline through Nextflow in order to demonstrate an alternative, more automated version of the 
RCP. 
Two configuration files for the dataset of interest must be created. The first configuration file 
should include information about the dataset, and the second configuration file will specify how 
to run the workflow on the HPC. The values in the configuration file are parameters that will be 
passed into the scripts run in the pipeline. Any of these can be removed and inputted manually 
into the scripts, if needed. Other parameters can also be added to the configuration file, to make 
the scripts more parameterized and generic. Figure 4 shows an example configuration file that 
can be used for GLDS-258.  
  
































Figure 4. Example configuration file for GLDS-258 
 
Figure 5 shows the standard executor configuration file used, which shows instructions for 
running on the HPC. However, it is not optimal. Executor configuration files can be formatted to 
utilize the Slurm job scheduler for more intensive jobs. This would allow Nextflow to use 
resources required by open tasks, while the standard configuration shown in Figure 5 will reserve 
all resources in the beginning of execution, despite the differing demands of the pipeline 
throughout the workflow. For instance, when initially downloading the data from NASA 
Genelab, there is essentially no computational resources needed, and all the allocated computing 
resources will sit idle. The optimal executor example configuration file can be found on the 




  // used for debugging to limit samples used 
  // default value here means no limit 
  limiter = -1 
 
  storeDirPath = '../workdir/GLDS-258/store' 
  publishDirPath = '../workdir/GLDS-258/publish' 
 
  // URLs to download data from GeneLab 
  GLDS_URL_PREFIX = 'https://genelab-
data.ndc.nasa.gov/genelab/static/media/dataset/GLDS-258_rna_seq_' 
  GLDS_URL_SUFFIX = '?version=1' // Assumption that these raw files 
are always version 1 
 
  // ensembl parameters for genome and annotations 
  genomeFasta = 'path/to/Homo_sapiens.GRCh38.dna.  
primary_assembly.fa' 
  genomeGTF = 'path/to/Homo_sapiens.GRCh38.102.gtf' 
  ensembl_version = 102 
 
  // source: https://genelab-
data.ndc.nasa.gov/genelab/accession/GLDS-258/ 
  // extracted from Sample Table, Column Sample Name 
  samples = ['GSM4066596, 'GSM4066597', 'GSM4066598', 
             'GSM4066599', 'GSM4066600', 'GSM4066601', 
             'GSM4066602', 'GSM4066603', 'GSM4066604', 
             'GSM4066605', 'GSM4066606', 'GSM4066607', 
             'GSM4066609', 'GSM4066608', 'GSM4066610', 
             'GSM4066611', 'GSM4066612', 'GSM4066613',] 
} 












Figure 5: Example of HPC executor configuration file used. 
 
D. Gene Set Analysis 
 
To understand the biological impact shown in the results, further analysis of the dataset can 
be performed using the results from the RCP. In particular, the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) and Gene Set Enrichment Analysis (GSEA) 




DAVID allows users to input a gene list of interest and view any biological meaning 
behind the set as a whole. For this project, DAVID version 6.8 was used. Since we are the most 
interested in the flight versus ground control group, we inputted all significantly expressed genes 
with an adjusted p-value of less than or equal to 0.05 using their Ensembl gene identifiers. The 
original study performed a DAVID analysis using regular p-values instead of adjusted p-values; 
for comparison purposes, this study also analyzes the gene set with a regular p-value of less than 




GSEA allows user to further understand the significance of complete pathways and 
relationships within their dataset. Analysis was completed with GSEA version 4.1.0 for Mac. 
GSEA was performed on 25,100 genes from the output of the DESeq2 analysis. MsigDB 
hallmark gene sets version 7.4 was used for comparison, along with MsigDB gene ontology 
biological process (GO BP) gene set version 7.2  
 
3) Leading Edge Analysis 
 
params { 
  executor = 'local' 
 
  withLabel: big_mem { 
    memory = 70.GB  
  } 
 
  withLabel: maxCPU { 
    cpus = 15 
  } 
} 
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Leading Edge Analysis (LEA) was conducted with GSEA version 4.1.0 for Mac. The GO 
BP gene set was used for LEA. A total of 830 gene sets from the GO BP gene set were selected 
for LEA because they had a nominal p-value of less than 0.05.  
 
III. RESULTS 
A. Data Quality Control 
 
 
Figure 6: FastQC Mean Quality Score graphs for (A) raw reads and (B) trimmed reads. 
 
A MultiQC report was generated for the raw reads and trimmed reads. Results from the 
MultiQC process showed that overall, all the reads are high quality since all samples had at least 
a read score of 28, indicated by the green region in the graphs in Figure 6A and Figure 6B. Each 
line on the graphs represents a unique sample. There are two distinct clusters of lines in both 
graphs in Figure 6. The clusters of lines with higher quality scores are the forward reads, while 
the clusters of lines with lower quality scores are the reverse reads. It is known that reverse reads 
tend to be lower quality than forward reads; however, the reason for this discrepancy is unknown 
 - 18 - 
[24]. Even so, the quality for both the forward and reverse reads are high enough quality to be 
able to confidently continue with the rest of the analysis process. 
In addition to the overall mean quality scores, the MultiQC report also reported other quality 
control scores. All samples had a sequence of 100 base pairs, as we expected. There were no 
samples with adapter contamination greater than 0.1%. Less than 1% of the reads for all samples 
were made up of overrepresented sequences. These results indicate that we can move forward 
with confidence for the rest of our analysis. 
  
B. STAR Alignment Analysis 
 
 
Figure 7: STAR Alignment Scores for all samples. 
 
After STAR Alignment was completed, another round of MultiQC was run to understand the 
overall quality of the alignment process. The alignment results for each sample are shown above 
in Figure 7. All samples had 84.6 or greater percentage of uniquely mapped reads, except sample 
SRR10084987, which is a flight sample from line two. Additionally, unmapped parts of samples 
due to being too short ranged from 3.6 to 8.5 percent. All samples mapped less than 0.1 percent 
to too many loci, except for post the singular flight sample from line 2. There were no reads from 
any sample in the other unmapped category.  
 
C. RSEM Counts Analysis 
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Figure 8: RSEM Mapped Reads for all samples. 
  
After RSEM counting results were completed, another round of MultiQC was performed to 
analyze the quality of the counts. All the samples had at least 84.9 percent of reads align 
uniquely to a gene, except for the flight sample from line two, which only had 76.1 percent of 
samples map uniquely to a gene. For all samples, 4.9 percent to 5.9 percent of reads were aligned 
to multiple genes, besides the flight sample from line two, which has 10.2 percent of reads 
aligned to multiple genes. 
 
D. DESeq2 Differential Gene Expression 
 
1) General Comparison to the Previous Study 
 
The original study conducted by Dr. Wu’s research group from Stanford University 
School of Medicine found 3,008 genes differentially expressed between ground and flight 
groups, 2,026 genes differentially expressed between post-flight and flight groups, and 1,049 
genes differentially expressed between post-flight and ground groups with p <= 0.05 using a 
two-tailed Student’s t test [13]. This project found similar results, with 3,010 genes differentially 
expressed between ground and flight groups, 1,295 genes differentially expressed between post-
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flight and flight groups, and 1,182 genes differentially expressed on a p-value of <= 0.05. The 
results of the two pipelines are shown in the bar graph in Figure 9. 
 
 
Figure 9: Comparison of differentially expressed genes  
between the RCP and Stanford’s data analysis pipeline. 
 
Additionally, this project focuses on the adjusted p-values instead of the p-values, to 
account for the false discovery rate due to multi-testing. The original study does not account for 
the false discovery rate. In terms of adjusted p-values for this project, there were 212 
differentially expressed genes between flight and ground control groups, 30 differentially 
expressed genes between flight and post-flight groups, and zero differentially expressed genes 
between ground control and post-flight groups.  
 
2) Principal Component Analysis  
 
The raw counts for this analysis contain raw, unnormalized counts for each sample. This 
indicates that the samples may have different read depths, which are the number of reads that 
come off the sequencer for each sample. After normalization of data using the DESeq2 
estimateSizeFactors() function, the new, normalized data can be plotted against the unnormalized 
counts data in two Principal Component Analysis (PCA) plots shown in Figure 10A and Figure 
10B. There is no considerable difference between Fig. X (A) and Fig. X (B). In both graphs, 
there are three distinct clusters, which correlate to the three cell lines used to create the hiPSC-
CMs. The original study also found that the samples clustered based on the three original cell 
lines [13]. 
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Figure 10: Principal Component Analysis for 
(A) raw data and (B) normalized data. 
 
In addition to plotting the unnormalized and normalized counts in PCA plots, the 
differentially expressed genes can be further visualized in a PCA plot. The normalized counts for 
the flight versus ground control group were filtered by an adjusted p-value of less than 0.05, then 
filtered by the log fold change greater than 1 and less than -1, and finally plotted. Figure 11 
shows the resulting PCA from this filtering process. Instead of clustering by cell line as shown in 
the previous PCA plots, the samples are now more closely clustered by their condition group. 
Ground control and post-flight samples are clustered slightly closer together in comparison to the 
flight group.   
 
 
Figure 11: Principal Component Analysis (PCA) of differentially 




A heatmap was created for the differentially expressed genes from the flight versus 
control group analysis. In Figure 12, the left most six samples represent the post-flight samples, 
the middle six samples represent the flight samples, and the last six samples represent the ground 
control samples. The differentially expressed genes number is 117, instead of the original 212, 
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because genes with not available names were removed. The post-flight and ground control 
samples columns on the heat map have similar levels of expression, while the flight samples 
have a visibly unique expression. 
  
 
Figure 12: Heatmap of differentially expressed genes 
from flight versus control groups across all samples 
 
E. Gene Set Analysis 
 
1) DAVID Gene Set Clusters 
 
Two gene sets were submitted to DAVID for analysis. First, the set of differentially 
expressed genes for fight versus control group p-values less than or equal to 0.05. This set was 
submitted to compare and contrast the results with the previous study conducted by Stanford 
University, since they also submitted a gene set with p-values less than 0.05. The second gene set 
submitted to DAVID was the list of differentially expressed genes between flight and post-flight 
groups, also with a p-value of less than or equal to 0.05. 
The first set of genes submitted has 3,010 differentially expressed genes based on a p-
value of less than or equal to 0.05. DAVID was able to recognize 2,506 genes as from the 
species Homo Sapiens and 503 genes were unknown. The top three enriched annotation clusters 
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displayed in Table I. The first cluster suggests that the Mitochondrion pathways were most 
heavily impacted from spaceflight and microgravity environments, with an enrichment score of 
26.43. The second cluster shows many impacts on pathways within the KEGG Pathway, with an 
enrichment score of 15.16. The final cluster shows expected impacts on the cardiac muscle 
contraction, as well as additional mitochondrial group disruptions. Since we are most interested 
in the flight versus ground control groups, key terms from the significant DAVID clusters were 
submitted to the PubMed search function to analyze how well-researched these topics were. 
While mitochondrial mechanisms and DNA damage and repair searches yielded many results, 
the neurodegenerative diseases from KEGG’s pathway do not seem as well researched. The 
query and their respective results are shown in Table III.  
The second set of genes was 1,295 genes from the post-flight versus flight groups. 
DAVID was able to recognize 1,019 of these genes as Homo Sapiens genes, while 275 were 
unknown. The top three enriched annotation clusters for these results are shown in Table II. 
There were far fewer significantly enriched groups in the post-flight versus flight groups in 
comparison to the flight versus group control groups. Additionally, the enrichment scores for this 
gene set are all much smaller than the enrichment group scores from the ground versus flight 
control group. The most significant cluster, the first cluster, indicates that DNA repair and 
damage mechanisms were impacted. This cluster has an enrichment score of 2.82. 
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TABLE I. 
TOP THREE ENRICHED ANNOTATION DAVID CLUSTERS 
FOR FLIGHT VERSUS GROUND CONTROL GROUPS 
Category Term Benjamini (FDR) 
Cluster 1, Enrichment Score: 26.43 
UP_KEYWORDS Mitochondrion 1.2E-41 
GOTERM_CC_DIRECT Mitochondrial inner membrane 2.4E-28 
UP_SEQ_FEATURE Transit peptide: Mitochondrion 1.9E-22 
UP_KEYWORDS Transit peptide 8.5E-24 
GOTERM_CC_DIRECT Mitochondrial matrix 8.1E-6 
Cluster 2, Enrichment Score: 15.16 
UP_KEYWORDS Mitochondrion inner membrane 1.2E-24 
KEGG_PATHWAY Parkinson’s disease 2.6E-21 
KEGG_PATHWAY Huntington’s disease 4.8E-19 
KEGG_PATHWAY Alzheimer’s disease 2.5E-18 
KEGG_PATHWAY Oxidative phosphorylation 3.0E-18 
UP_KEYWORDS Electron transport 4.7E-14 
UP_KEYWORDS Respiratory chain 7.7E-14 
KEGG_PATHWAY Non-alcoholic fatty liver disease 7.7E-12 
GOTERM_BP_DIRECT Mitochondrial respiratory chain 
complex I assembly 
2.4E-9 
GOTERM_CC_DIRECT Mitochondrial respiratory chain 
complex I 
4.0E-8 
GOTERM_BP_DIRECT Mitochondrial electron transport, 
NADH to ubiquinone 
6.0E-7 
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TABLE I. (CONTINUED) 
Cluster 3, Enrichment Score: 4.08 
KEGG_PATHWAY Cardiac muscle contraction 7.8E-6 
GOTERM_BP_DIRECT Mitochondrial electron transport, 
cytochrome c to oxygen 
2.7E-2 
GOTERM_MF_DIRECT Cytochrome-c oxidase activity 1.6E-1 
GOTERM_BP_DIRECT Hydrogen ion transmembrane 
transport 
2.5E-1 







TOP THREE ENRICHED ANNOTATION DAVID CLUSTERS 
FOR FLIGHT VERSUS POST-FLIGHT GROUPS 
Category Term Benjamini (FDR) 
Cluster 1, Enrichment Score: 2.82 
UP_KEYWORDS DNA damage 8.3E-2 
UP_KEYWORDS DNA repair 9.3E-2 
Cluster 2, Enrichment Score: 1.99 
UP_KEYWORDS ATP-binding 1.5E-2 
UP_KEYWORDS Nucleotide-binding 1.5E-2 
Cluster 3, Enrichment Score: 1.64 
UP_KEYWORDS WD repeat 9.8E-2 
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TABLE III. 
PUBMED RESULTS OF TOP DAVID CLUSTERS 
Query Number of Results 
“mitochondrial” microgravity 109 
“mitochondrial” spaceflight 92 
“DNA damage” microgravity 72 
“DNA damage” spaceflight 129 
“DNA repair” microgravity 64 
“DNA repair” spaceflight 86 
"Parkinson" microgravity 8 
"Parkinson" spaceflight 20 
"Alzheimer" microgravity 6 
"Alzheimer" spaceflight 16 
"Huntington" microgravity 5 
"Huntington" spaceflight 9 
 
 
2) GSEA Results 
 
There were 50 total gene sets in the MSigDB hallmark gene set used for comparison. 
These hallmark gene sets have well-known biological states and processes with consistent 
expression [25]. There were 24 gene sets that were significantly upregulated at a false discovery 
rate (FDR) of less than 25%, and five gene sets that were significantly downregulated, also at a 
FDR of less than 25%. This FDR is much higher than most gene set analyses, however, it was 
recommended by the GSEA software because the hallmark gene set has a small number of gene 
sets. Table IV show the significantly upregulated gene sets, and Table V shows the significantly 
downregulated gene sets. 
Leading edge analysis was performed with the GO BP gene sets. There was a total of 
830 gene sets with a p-value less than 0.05 that were chosen for leading edge analysis. The genes 
that had the highest number of counts across the gene sets are shown in Table VI. The leading 
edge analysis results can also be seen in Figure 12.  
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TABLE IV. 
GSEA UPREGULATED HALLMARK GENE SETS 





3.53 0.000 0.000 0.000 
HALLMARK_REACTIVE_OXYGEN_SPECIES_P
ATHWAY 
2.45 0.000 0.000 0.000 
HALLMARK_FATTY_ACID_METABOLISM 2.40 0.000 0.000 0.000 
HALLMARK_ADIPOGENESIS 2.38 0.000 0.000 0.000 
HALLMARK_MYOGENESIS 2.33 0.000 0.000 0.000 
HALLMARK_XENOBIOTIC_METABOLISM 2.16 0.000 0.000 0.000 
HALLMARK_MTORC1_SIGNALING 1.90 0.000 0.000 0.002 
HALLMARK_TNFA_SIGNALING_VIA_NFKB 1.90 0.000 0.000 0.002 
HALLMARK_HYPOXIA 1.87 0.000 0.001 0.005 
HALLMARK_P53_PATHWAY 1.77 0.000 0.001 0.009 
HALLMARK_UV_RESPONSE_UP  1.77 0.000 0.001 0.009 
HALLMARK_HEME_METABOLISM 1.76 0.000 0.001 0.011 
HALLMARK_CHOLESTEROL_HOMEOSTASIS 1.73 0.000 0.002 0.020 
HALLMARK_PEROXISOME 1.63 0.000 0.026 0.066 
HALLMARK_BILE_ACID_METABOLISM 1.49 0.011 0.025 0.285 
HALLMARK_DNA_REPAIR 1.48 0.004 0.026 0.210 
HALLMARK_APOPTOSIS 1.47 0.004 0.025 0.317 
HALLMARK_COAGULATION 1.46 0.012 0.029 0.373 
HALLMARK_ESTROGEN_RESPONSE_LATE 1.42 0.008 0.042 0.513 
HALLMARK_MYC_TARGETS_V1 1.41 0.011 0.043 0.531 
HALLMARK_GLYCOLYSIS 1.35 0.028 0.072 0.750 
HALLMARK_IL2_STAT5_SIGNALING 1.28 0.042 0.127 0.127 
HALLMARK_UNFOLDED_PROTEIN_RESPONSE 1.25 0.101 0.147 0.147 
HALLMARK_COMPLEMENT 1.19 0.129 0.228 0.228 
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TABLE V. 
GSEA DOWNREGULATED HALLMARK GENE SETS 




HALLMARK_MITOTIC_SPINDLE -1.69 0.000 0.011 0.016 
HALLMARK_G2M_CHECKPOINT -1.56 0.000 0.027 0.071 
HALLMARK_E2F_TARGETS -1.52 0.110 0.029 0.113 
HALLMARK_HEDGEHOG_SIGNALING -1.30 0.058 0.150 0.569 
HALLMARK_INTERFERON_ALPHA_RESPONSE -1.30 0.223 0.121 0.571 
 
 
TABLE VI.  
TOP LEADING EDGE ANALYSIS GENES 
Gene Name Expression Number of Gene Sets 
EDN1 Endothelin 1 Upregulated 97 
AGT Angiotensinogen Upregulated 87 
CAV3 Caveolin 3 Upregulated 84 
APOE Apolipoprotein E Upregulated 83 
PPARGC1A PPARG Coactivator 1 Alpha Upregulated 72 
APOA1 Apolipoprotein A1 Upregulated 69 
RYR2 Ryanodine Receptor 2 Upregulated 69 
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IV. DISCUSSION 
 
A. Computational Resources 
 
The combined total of all GLDS-258 raw RNA-Seq data is over 43 GB. This large amount of 
data creates a bottleneck effect in the beginning of the pipeline, causing the entire workflow to 
await the completion of this download. Thus, computing environments with sufficient download 
speed are required to complete the RCP in a timely manner. 
Large amounts of RAM are needed to process data through the RCP. The process that 
required the most memory was STAR alignment, which required 80 GB of RAM. This value was 
reached through repeated trial and error by modifying the parameter #SBATCH –-mem=80000 
in the Slurm script until it was able to run successfully. The –-mem parameter in Slurm indicates 
the amount of real memory required per node [26]. In addition, the STAR alignment parameter –
-limitBAMsortRAM was increased to 70,000,000,000 for there to be enough memory for 
BAM sorting during STAR alignment. –-limitBAMsortRAM allocates the maximum 
available RAM in bytes for sorting BAM [21]. This large amount of RAM needed is a trade-off 
for the fast mapping speed of the program [21], and suggests that this step in the RCP can also 
create a bottleneck effect. 
Another process that required a large amount of RAM was the STAR reference building 
process. The parameter #SBATCH –-mem=60000 was used to build the Homo Sapiens 
reference. The reference must be recreated if the user wishes to use newer version of the 
Ensembl releases. Otherwise, a reference genome only needs to be built once for any organism, 
and the resulting output files can be reused for any dataset from that organism. The files 
produced from STAR reference building are extremely large, totaling up to over 30GB. If users 
wish to reuse the reference genome on another system, it may be not time efficient to repeatedly 
copy the files to multiple computers. In this case, it may just be faster to run the script and build 
the reference on the new system, which should take three to four hours.  
An option that may be helpful in the future is to consider compressing the reference files and 
hosting it on cloud storage solution, such as Amazon Web Services Simple Storage Service. This 
option would allow users to build the reference for any organism once, persist the files onto 
cloud storage, and download them from any location or computer. Then, the STAR reference 
building process could be removed from the RCP and would decrease the total computational 
load significantly. 
 
B. Raw and Trimmed Data Quality Analysis 
 
The average quality of all the raw and trimmed reads were above 28; 28 is the lower 
boundary for a good quality read. There are two distinct clusters within both raw and trimmed 
mean quality score graphs in Figure 6A and Figure 6B. The cluster in both graphs with higher 
average quality scores are the forward reads, while the cluster with lower average quality scores 
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are the reverse reads. This is a known issue with Illumina sequencing, and the cause is not yet 
known, as previously mentioned [24]. This issue may be countered by using a different next 
generation sequencing technology. However, Illumina sequencing has almost two thirds of the 
market share in the next generation sequencing market because it’s cost effective, even though 
it’s less accurate than other technologies on the market [24]. Moreover, most of the existing 
GeneLab datasets were sequenced on Illumina technology. 
FastQC and MultiQC are the technologies that are used for quality control in the RPC. These 
two technologies are largely popular in the bioinformatics field; however, there are other 
technologies that may provide more insight into the quality of sequencing data. Technologies for 
quality control, including FastQC, htSeqTools, and SAMState only focus on raw sequence 
metrics [27]. A possible alternative, RNA-SeQC is a tool that considers additional checks, such 
as saturation checking [27]. Thus, future versions of the RCP should consider expanding the use 
of quality control technologies to produce more insight on the quality of sequenced data.  
 
C. STAR Alignment and RSEM Mapped Reads  
 
1) Quality Analysis 
 
STAR Alignment scores in Figure 7 all are good quality due to the high percentage of 
uniquely mapped reads. The only sample that does not have a high percentage of uniquely 
mapped reads is SRR10084987, which is the flight sample from line two. A lower number of 
uniquely mapped reads can indicate that there are more reads mapping to multiple loci. This can 
also be seen for sample SRR10084987 in Figure 7, which has many reads mapped to multiple 
loci in comparison to all the other reads.  
MultiQC results of RSEM mapped reads in Figure 8 show that all samples have good 
quality mapping, except for sample SRR10084987. This is expected after viewing the poor 
alignment results for the same sample in Figure 7.   
It is important for reads to be uniquely aligned to the reference for accurate quantification 
[28]. There are various biological mechanisms that may contribute to the appearance of sequence 
duplication, such as recombination, transposable elements, and alternative splicing. [29]. 
However, it seems unlikely that the duplication apparent in sample SRR10084987 would be due 
to biological mechanisms, since it is not present in any of the other samples. Instead, other 
external factors may have affected the mapped read results for sample SRR10084987. 
 
2) Comparison to Previous Study 
 
The study from Dr. Wu’s research group at Stanford University used a variety of 
different technologies and references, which could account for some of the differences shown in 
Figure 9. Table VII shows the similarities and differences between this project and the Stanford 
University publication. 
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The first major difference between the two studies is the tool used for alignment. Based 
on a previous study comparing the performance of HISAT2 and STAR, the two programs tend to 
have a large number of overlapping reads that will map to the same area in the reference genome  
[30]. STAR, however, had a higher mapping rate and more mapped reads in comparison to 
HISAT2 in this study [30]. 
The next difference is the choice of quantification tool used. A previous study found that 
RSEM for isoform quantification is more aligned with the true count values, while featureCounts 
tends to undercounts the samples when using idealized data with no indels, no single nucleotide 
polymorphisms, and other modifications [31]. However, with more realistic data, featureCounts 
was found to have more accurate counts [31]. This is only a single study, and a definitive answer 
regarding which quantification tool is better is not possible. Both tools are different and have 
their respective advantages and disadvantages. These differences can explain some of the 
variation found in the results when comparing the two studies. 
The final major difference between the two analysis workflows are the reference genome 
and annotations. Wu’s study uses Ensembl 85, which was released in July 2016. This project 
uses Ensembl 102, which was released in December 2020. One major update in Ensembl 102 for 
the human genome was an update that translates any non-ATG start codons to Methionine. This 
difference is another factor that could have contributed to the difference in results for this project 
compared to the Stanford University publication. 
 
TABLE VII.  
COMPARISON OF RESOURCES USED BETWEEN STUDIES 
Resource This Project Wu [13] 
Alignment STAR HISAT2 
Quantification RSEM featureCounts 
Human genome hg38 hg38 
Annotation Ensembl 103 (Homo Sapiens) Ensembl 85 (Homo Sapiens) 
 
D. Differential Gene Expression 
 
There are several tools designed for differential gene expression analysis, including two 
popular choices of DESeq2 and edgeR [32]. Both tools are based on a negative binomial model 
distribution. When estimating dispersion factors, DESeq2 will use all genes with similar 
expression. In contrast, edgeR combines any common dispersions among genes that is estimated 
using a likelihood method and adds this two a gene-specific dispersion [32]. DESeq2 and edgeR 
are both solid choices for differential gene expression. 
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Further study into the DESeq2 package shows that there is a function DESeq() that calls 
the functions estimateSizeFactors(), estimateDispersions(), and nbinomWaldTest() 
automatically. There were no arguments included in these three function calls. Since the R script 
used in this project manually calls all of these functions, the script could be further optimized by 
directly calling the DESeq() function. Readability of the code would remain high since there are 
no additional arguments required for this project. 
 
E. Gene Set Analysis 
 
1) DAVID Enriched Clusters Results 
 
The most significant enrichment found for flight versus ground control groups in Wu’s 
study was the mitochondrion and transit peptide groups with an enrichment score of 48.87 [13]. 
This group was also found in this project’s flight versus ground control groups to be the most 
enriched, with an enrichment score of 26.43 as shown in Table I. Other similar enrichment scores 
between the two include electron transport and mitochondrial respiratory chain scores at 14.7 and 
15.16 for Wu’s study and this project, respectively [13]. The results which indicate that 
mitochondrial metabolism is altered due to microgravity align Wu’s study, as well as with 
previous studies [13]. Rat cardiac muscle cells have been shown to have increased expression in 
the mitochondrial metabolism pathway in microgravity environments [10]. Human cells have 
also shown different amounts of mitochondrial pathway gene expression in the NASA Twins 
Study [7]. However, Parkinson’s disease, Huntington’s disease, and Alzheimer’s disease, three 
terms from the KEGG PATHWAY group in Table I cluster 1, had high enrichment scores of 
15.16 but were not mentioned in Wu’s study. The KEGG PATHWAY is a set of various known 
molecular pathways, including those about human diseases [33]. 
The top enriched clusters for post-flight versus flight groups, as shown in Table II, 
includes DNA damage and DNA repair groups, with an enrichment score of 2.82. This aligns 
well with the known knowledge that space radiation can cause DNA damage because of the 
interaction between charged particles and DNA [34]. Previous studies have also shown that DNA 
repair mechanisms expression is changed in microgravity environment, which can consequently 
increase the amount of DNA damage in human cells [35]. It is interesting, however, that the 
DNA damage and repair clusters are not present in Table I. It is possible that the hiPSC-CMs on 
the ISS return to similar levels of expression as ground controls after being returned to Earth 
[14]. This is supported by the similar levels of expression from the post-flight and ground control 
groups, shown in Figure 12. The DNA damage and repair expression may have been 
overshadowed by the large amounts of differential expression presented in the first three clusters 
in Table I, as supported by the large enrichment values. This suggests that much of the highly 
enriched mitochondrial mechanisms shown in Table I return to normal, less enriched levels upon 
return to Earth. DNA damage and repair pathways, however, may still be affected 10 days post-
flight. 
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2) GSEA Upregulated Hallmark Gene Sets 
 
GSEA is an important tool when studying differential expression because it analyzes an 
entire gene set, instead of only significantly expressed genes. This allows the program to see 
entire pathways or mechanisms that may have been impacted by microgravity and gives the user 
and opportunity to see the results as a whole picture, instead of gene by gene. The hallmark gene 
sets were chosen for this project because it is considered a good starting point for analyses that 
are looking for general insight into their dataset. 
 The most upregulated gene set is the oxidative phosphorylation gene set. Oxidative 
phosphorylation a process that takes place within the mitochondria and is the primary energy 
source for human cells [36]. The upregulation of this gene set aligns well with the results from 
the DAVID analysis, since the mitochondrial pathways had high enrichment scores. The second 
most upregulated gene set is the reactive oxygen species pathway. The reactive oxygen species 
pathway plays an important role in regulating various cellular processes [37]. Previous studies 
have shown that an overproduction of reactive oxygen species may promote neurogenerative 
disorders, such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease [38]. This 
upregulation in this hallmark gene set matches extremely well with the enriched 
neurodegenerative diseases shown in the DAVID cluster 1 in Table 1. 
Upregulated genes shown in Table VI from the leading edge analysis shows upregulation 
in several genes including AGT and APOE. APOE, or Apolipoprotein E, may have isoforms that 
can affect the lipid metabolism, which can in turn affect degenerative processes [39]. This could 
also be a contributing factor for the third most upregulated hallmark gene set, the fatty acid 
metabolism, shown in Table IV. AGT, or Angiotensinogen, has been shown to increase oxidative 
stress, which is related to the oxygen reactive species, and cause neuroinflammation and 
neurodegeneration [40]. This is another example of how one of the upregulated hallmark gene 
sets, the oxygen species pathway, correlates with the leading edge analysis genes.   
 
3) GSEA Downregulated Hallmark Gene Sets 
 
The downregulated top three significant hallmark gene sets, including mitotic spindle, 
G2M checkpoint, and E2F targets are all related to the cell division cycle. This is particularly 
puzzling given that adult cardiomyocytes do not divide [5]. However, hiPSC-CMs have 
previously been shown to have had their cell cycles activated [41]. It is unclear whether the 
hiPSC-CMs used for this experiment are cell cycle activated cardiomyocytes. Further research is 
required particularly for the downregulated hallmark gene sets to reach a more definitive answer. 
 
4) Spaceflight, Cardiomyocytes, and Neurodegenerative Diseases 
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The neurodegenerative disorders presented under Cluster 2 in Table I, are not mentioned 
in Wu’s study. Neurodegenerative disorders typically include a steady loss of neurons, which can 
cause dementia, poor motor skills, among other symptoms [42]. The high enrichment scores of 
the neurodegenerative disorders indicate that exposure to microgravity may play a role in 
altering expression of genes which are related to neurodegenerative pathways in cardiac cells. 
Although many neurological disorders are not typically thought to have any association with the 
cardiovascular system, there is evidence that heart defects could aid in the progression of 
neurodegenerative diseases [43]. In particular, huntingtin, the protein responsible for 
Huntington’s disease, is expressed in both cardiovascular and nervous systems [43]. Another 
study proposes that in order to prevent microgravity-induced neurodegeneration, possible 
hypergravity therapy could be performed on individuals who are in space [44]. There has also 
been evidence from multiple studies that cardiac sympathetic nerve degenerates in the beginning 
stages of Parkinson’s disease [45], [46]. The exact correlation between cardiomyocytes and 
neurodegenerative diseases remains unclear. However, the possible connection between the two 
as shown in previous studies and this project set the groundwork for possible discoveries in the 
future. 
Previous studies have also investigated the link between neurodegenerative diseases and 
mitochondrial pathways. This relationship is relevant to this project because of the significant 
amount of expression in mitochondrial pathway genes. One study suggests that damage to the 
mitochondrial oxidative process is a major change that typically happens in the later stages of 
neurodegenerative diseases [47], Apoptosis, or programmed cell death, are controlled by 
mitochondria and often modified in neurodegenerative diseases, thus leading to 
neurodegeneration [48] 
Cardiomyocytes and neurodegenerative diseases seem to be linked through the close 
connections of the cardiovascular and nervous system. The interactions between the different 
pathways presented in the project are complex, but consistent. Cardiomyocytes in microgravity 
environments may have differential expression of certain genes and pathways, which could be 




This project implemented the NASA RCP to analyze the GLDS-258 dataset, which studies 
hiPSC-CMs in a microgravity environment. There is an available Nextflow implementation of 
the RCP for Mus musculus datasets, and this project briefly explains what changes are required 
to run a Homo Sapiens dataset through the Nextflow implementation of the RPC. Analysis was 
completed on output data from running the pipeline manually since the Nextflow implementation 
is not official and still in development. The pipeline was run on the College of Engineering HPC, 
which provides sufficient resources for the computational tasks required. Most RNA-Seq 
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experiments have millions of base pairs to sequence, and therefore, will also require immense 
computing power.   
Overall, the quality of the dataset was good, except for one sample when compared to the 
others 18. Even so, the quality of the worst sample was still acceptable and therefore the 
experiment was able to move forward. The next steps of the pipeline, STAR alignment and 
RSEM quantification, also produced good quality data. Thus, we were able to confidently run 
DESeq2 analysis was able to create a matrix of differentially expressed genes ready to be 
analyzed in gene set analysis. 
Two types of gene set analysis were performed, including DAVID and GSEA. DAVID 
provided insight into the clusters of genes that were most enriched. GSEA provided information 
on upregulated and downregulated hallmark gene sets. There is a large amount of significant 
hallmark data sets in this project that have yet to be analyzed in depth and will require future 
study to fully understand. 
When comparing to a previous study completed regarding GLDS-258, this study was able to 
have similar findings regarding significant expression of mitochondrial pathways. This project 
was also able to inspect some new information not mentioned in the previous study regarding 
neurodegenerative diseases. Previous works have touched on the relationship between the 
cardiovascular system and the nervous system, but no in-depth mechanisms have yet to be 
determined when relating pathways from the two systems. This project also explores the 
relationship between regulating mitochondrial pathways, and how they may affect 
neurodegenerative diseases. Overall, there seems to be an extremely complex web of interactions 
and gene expression cascades which can affect multiple parts of the human body. 
This project was the very first Homo Sapiens dataset run through the RCP. Hopefully, this 
study can provide more insight into future analysis of Homo Sapiens datasets on the RCP, as 
well as possible links between the cardiovascular system and the nervous system. Analyzing the 
datasets from NASA GeneLab is an essential part to understanding how the human body works 
on Earth and in space. With more people traveling to space in the coming years, it is important to 
remain vigilant in trying to protect our astronauts’ safety while they are in space. This effort will 
hopefully allow for increased space travel and more questions answered about the limitations of 
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